The Val34Leu genetic variation in the A Subunit of Coagulation Factor XIII in recurrent spontaneous abortion

Systems Biology in Reproductive Medicine

Volumn 57, Issue 5, 2011, Pages 261-264

  Bagheri, Morteza ^a   Rad, Isa Abdi ^b   Omrani, Mir Davood ^a   Nanbaksh, Fariba ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Factor; RSA; Val34Leu; XIII

Indexed keywords

BLOOD CLOTTING FACTOR 13; LEUCINE; VALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ALLELES; FACTOR XIII; FEMALE; GENETIC VARIATION; HUMANS; LEUCINE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; VALINE;

EID: 80053382187     PISSN: 19396368     EISSN: 19396368     Source Type: Journal    
DOI: 10.3109/19396368.2011.576308     Document Type: Article

References (41)

1. Anwar, R., Gallivan, L., Edmonds, S.D. and Markham, A.F. (1999) Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 93(3):897-905. (Pubitemid 29067854)
2. Ariëns, R.A., Lai, T.S., Weisel, J.W., Greenberg, C.S. and Grant, P.J. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100(3):743-754. (Pubitemid 34832596)
3. Attié-Castro, F.A., Zago, M.A., Lavinha, J., Elion, J., Rodriguez-Delfin, L., Guerreiro, J.F. and Franco, R.F. (2000) Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 84 (4):601-603.
4. Balogh, I., Szôke, G., Kárpáti, L., Wartiovaara, U., Katona, E., Komáromi, I., et al. (2000) Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 96(7):2479-2486.
5. Barbosa, H.C., Carvalho, E.C., Barini, R., Siqueira, L.H., Costa, D.S. and Annichino-Bizzacchi, J.M. (2004) Tyr204Phe and Val34Leu polymorphisms in two Brazilian ethnic groups and in patients with recurrent miscarriages. Fertil Steril 82(5):1455-1457. (Pubitemid 39469479)
6. Board, P.G., Webb, G.C., McKee, J., and Ichinose, A. (1988) Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24-p25. Cytogenet Cell Genet 48(1): 25-27. (Pubitemid 18265292)
7. Catto, A.J., Kohler, H.P., Coore, J., Mansfield, M.W., Stickland, M.H. and Grant, P.J. (1999) Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 93(3):906-908. (Pubitemid 29067855)
8. Cho, K.H., Kim, B.C., Kim, M.K., Shin and B.A. (2002) No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population. J Korean Med Sci 17: 249-253.
9. Chung, S.I., Lewis, M.S. and Folk, J.E. (1974) Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J Biol Chem 249(3): 940-950.
10. Coulam, C.B., Jeyendran, R.S., Fishel, L.A. and Roussev, R. (2006) Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 55(5):360-368.
11. Cross, J.C., Werb, Z. and Fisher, S.J. (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266 (5190):1508-1518.
12. Dossenbach-Glaninger, A., van Trotsenburg, M., Schneider, B., Oberkanins, C., and Hopmeier, P. (2008) ACE I/D polymorphism and recurrent first trimester pregnancy loss: interaction with SERPINE1 4G/5G and F13 Val34Leu polymorphisms. Br J Haematol; 141(2):269-271. (Pubitemid 351406219)
13. Dossenbach-Glaninger, A., van Trotsenburg, M., Dossenbach, M., Oberkanins, C., Moritz, A., Krugluger, W., et al. (2003) Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49(7):1081-1086. (Pubitemid 36751094)
14. Duckert, F. (1972) Documentation of the plasma factor XIII deficiency in man. Ann N Y Acad Sci 202:190-199.
15. Elbaz, A., Poirier, O., Canaple, S., Chédru, F., Cambien, F. and Amarenco, P. (2000) The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 95 (2):586-591. (Pubitemid 30041674)
16. Feng, Q., Liu, Y., Liu, K., Byrne, S., Liu, G., Wang, X., et al. (2000) Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Placenta 21(2-3):184-193. (Pubitemid 30240784)
17. Floridon, C., Nielsen, O., Hoølund, B., Sweep, F., Sunde, L., Thomsen, S.G. and Teisner, B. (2000) Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 21 (8):754-762.
18. Franco, R.F., Middeldorp, S., Meinardi, J.R., van Pampus, E.C. and Reitsma, P.H. (2000) Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers. Br J Haematol 111 (1):118-121.
19. Goodman, C.S., Coulam, C.B., Jeyendran, R.S., Acosta, V.A. and Roussev, R. (2006) Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 56 (4):230-236. (Pubitemid 44288651)
20. Ichinose, A. and Davie, E.W. (1988) Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 85 (16):5829-5833.
21. Ivaskevicius, V., Biswas, A., Bevans, C., Schroeder, V., Kohler, H.P., Rott, H., et al. (2010) Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 95(6):956-962.
22. Ivaskevicius, V., Biswas, A., Loreth, R., Schroeder, V., Ohlenforst, S., Rott, H., et al. (2010) Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 16(4):675-82.
23. Ivaskevicius, V., Seitz, R., Kohler, H.P., Schroeder, V., Muszbek, L., Ariens, R.A., et al. (2007) International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 97(6): 914-921. (Pubitemid 46947830)
24. Jeddi-Tehrani, M., Torabi, R., Mohammadzadeh, A., Arefi, S., Keramatipour, M., Zeraati, H., et al. (2010) Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss. Am J Reprod Immunol 64(3):212-217.
25. Kangsadalampai, S. and Board, P.G. (1998) The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:2766-2770. (Pubitemid 28469090)
26. Kohler, H.P., Ariëns, R.A., Whitaker, P. and Grant, P.J. (1998) A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 80(4):704. (Pubitemid 28479365)
27. Kohler, H.P. and Grant, P.J. (1998) Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction. Thromb Haemost 80(5):862. (Pubitemid 28521738)
28. Kohler, H.P., Stickland, M.H., Ossei-Gerning, N., Carter, A., Mikkola, H. and Grant, P.J. (1998) Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79(1):8-13. (Pubitemid 28037047)
29. Lewis, S.D., Janus, T.J., Lorand, L. and Shafer, J.A. (1985) Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry 24 (24):6772-6777. (Pubitemid 16170204)
30. López Ramírez, Y., Vivenes, M., Miller, A., Pulido, A., López Mora, J., Arocha-Piñango, C.L. and Marchi, R. (2006) Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. Clin Chim Acta 374(1-2):69-74. (Pubitemid 44572237)
31. Lorand, L., Losowsky, M.S., and Miloszewski, K.J.M. (1980) Human factor XIII fibrin stabilising factor. Progr ThrombHaemost 5:245-290.
32. Meyer, M. (2004) Molecular biology of haemostasis: fibrinogen, factor XIII. Hamostaseologie 24: 108-115. (Pubitemid 38714909)
33. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215.
34. Muszbek, L. (2000) Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost 84:524-527.
35. Rallidis, L.S., Politou, M., Komporozos, C., Panagiotakos, D.B., Belessi, C.I., Travlou, et al. (2008) Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost 99(6):1085-1089. (Pubitemid 351810491)
36. Shafey, M., Anderson, J.L., Scarvelis, D., Doucette, S.P., Gagnon, F. and Wells, P.S. (2007) Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 97 (4):635-641. (Pubitemid 46592942)
37. Suzuki, K., Henke, J., Iwata, M., Henke, L., Tsuji, H., Fukunaga, G.I., et al. (1996) Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet 98:393-395. (Pubitemid 26336160)
38. Vossen, C.Y., and Rosendaal, F.R. (2005) The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level. J Thromb Haemost 3 (5):1102-1103. (Pubitemid 41632850)
39. Wartiovaara, U., Perola, M., Mikkola, H., Tötterman, K., Savolainen, V., Penttilä, A., et al. (1999) Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142(2):295-300. (Pubitemid 29059487)
40. Webb, G.C., Coggan, M., Ichinose, A. and Board, P.G. (1989) Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet 81(2):157-160. (Pubitemid 19039861)
41. Wells, P.S., Anderson, J.L., Scarvelis, D.K., Doucette, S.P. and Gagnon, F. (2006) Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 164(2):101-109. (Pubitemid 43992174)